Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: The collaborative hospital transfusion study

Transfusion

Volumn 36, Issue 6, 1996, Pages 521-532

  Surgenor, D M ^a   Churchill, W H ^b   Wallace, E L ^c   Rizzo, R J ^b   Chapman, R H ^a   Mcgurk, S ^a   Bertholf, M F ^d   Goodnough, L T ^e,f   Kao, K J ^g   Koerner, T A W ^h   Olson, J D ^h   Woodson, R D ⁱ  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Center for Management Systems   (United States)

^d Florida Georgia Blood Alliance   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BARNES JEWISH HOSPITAL   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA TRANSFUSION; THROMBOCYTE TRANSFUSION; TREATMENT INDICATION;

EID: 8944244054     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36696269511.x     Document Type: Article

References (27)

1. Bayer WL, Coenen WM, Jenkins DC, Zucker ML. The use of blood and blood component in 1,769 patients undergoing open-heart surgery. Ann Thorac Surg 1980;29:117-22.
2. Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
3. Surgenor DM, Wallace EL, Churchill WH, et al. Red cell transfusions in coronary artery bypass surgery (DRGs 106 and 107). Transfusion 1992;32:458-64.
4. Sirchia G, Giovanetti AM, McClelland DBL, Fraccia GN, eds. Safe and good use of blood in surgery (Sanguis), use of blood products and artificial colloids in 43 European hospitals. Luxembourg: Office of Publications of the European Communities, 1994.
5. Use of blood products for elective surgery in 43 European hospitals. The Sanguis Study Group. Transfus Med 1994;4:251-68.
6. Consensus conference. Platelet transfusion therapy. JAMA 1987;257:1777-80.
7. Consensus conference. Fresh-frozen plasma. Indications and risks. JAMA 1985;253:551-3.
8. McCullough J. The nation's changing blood supply system. JAMA 1993;269:2239-45.
9. Surgenor DM, Wallace EL, Hao SH, Chapman RH. Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 1990;322:1646-51.
10. Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995;35:802-12.
11. DRGs, diagnosis related groups: definitions manual. 11th revision. New Haven, CT: Health Systems International, 1994.
12. International classification of diseases. 9th revision. Clinical modification: ICD-9-CM 4th edition. DHHS publication no. (PHS) 80-1260. Washington: Government Printing Office, 1993.
13. Hannan EL, Kilburn H Jr, Racz M, et al. Improving the outcomes of coronary artery bypass surgery in New York State. JAMA 1994;271:761-6.
14. Busch MP, Korelitz JJ, Kleinman SH, et al. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. Transfusion 1995;35:903-10.
15. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-5.
16. Churchill WH, Chapman RH, Rutherford CJ, et al. Blood product utilization in hip and knee arthroplasty: effect of gender and autologous blood on transfusion practice. Vox Sang 1994;66:182-7.
17. Cosgrove DM, Loop FD, Lytle BW, et al. Determinants of blood utilization during myocardial revascularization. Ann Thorac Surg 1985;40:380-4.
18. Friedman BA, Burns TL, Schork MA. An analysis of blood transfusion of surgical patients by sex: a quest for the transfusion trigger. Transfusion 1980;20:179-88.
19. Loop FD, Lytle, BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314:1-6.
20. Spencer FC. The internal mammary artery: the ideal coronary bypass graft? (editorial). N Engl J Med 1986;314:50-1.
21. Cosgrove DM, Lytle BW, Loop FD, et al. Does bilateral internal mammary artery grafting increase surgical risk? J Thorac Cardiovasc Surg 1988;95:850-6.
22. Valeri CR, Khabbaz K, Khuri SF, et al. Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg 1992;104:108-16.
23. Ferraris VA, Gildengorin V. Predictors of excessive blood loss after coronary artery bypass grafting. A multivariate analysis. J Thorac Surg 1989;98:492-7.
24. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680-97.
25. Kruskall MS. On measuring the success of an autologous blood donation program (editorial). Transfusion 1991;31:481-2.
26. Graves EJ. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1991. Vital Health Stat 13 1994;115:1-290.
27. Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995;35:802-12.